Zobrazeno 1 - 10
of 43
pro vyhledávání: '"этилметилгидроксипиридина сукцинат"'
Autor:
S. V. Radko, A. D. Dulepov
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 1, Pp 3-5 (2019)
An assessment of the influence of 2-ethyl-6-methyl-3-hydroxypyridine succinate (Mexidol) on the physical performance of small laboratory animals and recovery after exercise was made. As a result, it was found that a single application of Mexidol incr
Externí odkaz:
https://doaj.org/article/b4f5db5b394d4a539ce472bdd24b6cc5
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 35-37 (2018)
The article presents the new possibilities of preventing the onset of irreversible myocardial damage during ischemia and effective approaches undertaken in the early reperfusion period (per - and postconditioning of the myocardium) through coronary t
Externí odkaz:
https://doaj.org/article/a606291c7aab415892d58bf1f72c98ae
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL; № 7.101 (2018); 28-33
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 28-33
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 28-33
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 28-33
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 28-33
У дослідженні показано, що додавання до комплексної інтенсивної терапії гострого періоду тяжкої черепно-мозкової травми етилметилгідр
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 3, Pp 420-423 (2015)
Aim. To study the effect of ethylmethylhydroxypyridine succinate (EMHPS) on the protein oxidative modification (POM) in patients with acute ischemic stroke. (IS) Material and methods. Patients with IS (n=80) and 20 healthy subjects matched for age an
Externí odkaz:
https://doaj.org/article/35220cc0f5d745fc9acd181c3e60173c
Autor:
A. D. Ehrlikh, N. A. Gratsianskii
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 4, Pp 448-456 (2015)
Review of clinical studies on the use of ethylmethylhydroxypyridine succinate (EMHPS) medications in patients with stroke and its consequences is presented. EMHPS drugs are widely used in routine clinical practice in Russia, despite the absence of cl
Externí odkaz:
https://doaj.org/article/5f9e8a953c294f428d40f82e8c705186
Autor:
I. I. Pavlyuchenko, N. M. Bat
Publikováno v:
Кубанский научный медицинский вестник, Iss 4, Pp 102-105 (2015)
Disorders of hypoxic and free radical origin as they rise can lead to the destruction of cells and, consequently, often determine the fate of the organ, tissue and ultimately the whole organism. Hence, the relevance of using high-performance antihypo
Externí odkaz:
https://doaj.org/article/069b5d9bcc7946d4b93cb9bc687a5b4f
Publikováno v:
Surgery of Ukraine; № 2 (2019); 20—25
Хирургия Украины; № 2 (2019); 20—25
Хірургія України; № 2 (2019); 20—25
Хирургия Украины; № 2 (2019); 20—25
Хірургія України; № 2 (2019); 20—25
The aim — to analyze the efficacy of ethyl methylhydroxypyridine succinate (Lodixem) and the combination of ethylmethylhydroxypyridine succinate and pentoxifylline in a Ringer Lactate solution (Lodixem + Latren) in the treatment of patients with ac
Autor:
Chursina, T.Ya., Mikhaliev, K.O.
Publikováno v:
EMERGENCY MEDICINE; Vol. 16 No. 7-8 (2020); 33-41
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16 № 7-8 (2020); 33-41
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16 № 7-8 (2020); 33-41
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16 № 7-8 (2020); 33-41
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16 № 7-8 (2020); 33-41
Community-acquired pneumonia is one of the most common infectious diseases of the 21st century and remains an important medical and social problem due to the relatively high rates of disability and mortality, as well as significant economic losses. C
Publikováno v:
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16, № 5 (2020); 80-86
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16, № 5 (2020); 80-86
EMERGENCY MEDICINE; Том 16, № 5 (2020); 80-86
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16, № 5 (2020); 80-86
EMERGENCY MEDICINE; Том 16, № 5 (2020); 80-86
Background. The urgency of the problem of postoperative cognitive dysfunction (POCD) is due to the high frequency of its development (up to 30 % in non-cardiac surgery patients), which entails a number of psychosomatic complications with the need for
В обзоре обсуждается современный обоснованный подход к выбору антигипертензивных и нейропротективных лекарственных средств (ЛС) для л
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b852e9e0e9afbcf33e39cee6c950fe18